CD4 and acute lymphoblastic leukemia: In addition, SUP-T1 cells (lymphoblastic lymphoma-derived CD4+ T cell line), and the acute lymphoblastic leukemia-derived CD4+ T cell lines CEM and MOLT-3, were evaluated by immunoblot with these antibodies.